| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |